Adline Chem Lab Ltd.

View in App
6.55 ▼0%

06 June 2023, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kamronlabs.com
Market Cap 3.83 Cr.
Enterprise Value(EV) 5.12 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -7.24 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share -2.71 Trailing Twelve Months Ending 2023-03
Price to Book Value -2.42 Calculated using Price: 6.55
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.59 Cr. 5,850,000 Shares
FaceValue 10
About Adline Chem Lab Ltd.
The company is engaged primarily in business of manufacturing pharmaceutical products. The company has also stared trading in grey fabrics.

Adline Chem Lab Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Adline Chem Lab Ltd. Performance

View details >>
1 Day
1 Week
+4.97%
1 Month
+21.30%
3 Month
+27.18%
6 Month
-8.65%
1 Year
-25.14%
2 Year
+28.43%
5 Year
+11.97%
10 Year

Adline Chem Lab Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.14 0.42 0.20 0.21 0.06 1.02 -127.09 -49.89 31.35
Return on Capital Employed (%) 4.75 3.83 3.16 2.46 2.55 0.93 -49.36 -23.82 16.18
Return on Assets (%) 0.05 0.13 0.06 0.04 0.01 0.12 -25.58 -19.42 13.66

Adline Chem Lab Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 7 7 7 7 7 7 3 2 3 -2
Non Curr. Liab. 5 6 5 4 4 0 0 0 0 0
Curr. Liab. 5 6 7 9 12 15 4 3 2 1
Minority Int.
Equity & Liab. 17 19 18 21 23 22 8 6 5 0
Non Curr. Assets 10 12 12 13 13 12 5 4 4
Curr. Assets 5 6 5 5 7 6 3 2 0 0
Misc. Exp. not W/O 2 1 2 3 4 4
Total Assets 17 19 18 21 23 22 8 6 5 0

Adline Chem Lab Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 13 15 17 17 8 6 7 6 1
Other Income 0 0 0 0 0 0 0 0 0 1
Total Income 13 15 17 17 8 6 7 6 1 1
Total Expenditure -12 -14 -16 -16 -7 -5 -10 -7 -1 -1
PBIDT 1 1 1 1 1 1 -3 0 0 0
Interest -1 0 0 0 0 0 0 0 0
Depreciation 0 -1 0 -1 -1 -1 0 -1 0 0
Taxation 0 0 0 0 0
Exceptional Items 0 1 -4
PAT 0 0 0 0 0 -4 -1 1 -4
Adjusted EPS 0 0 0 0 0 -6 -2 1 -7

Adline Chem Lab Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 1 0 1 2 1 -1 -11 0 0
Cash Fr. Inv. -1 -1 -2 0 -3 -3 0 11 0
Cash Fr. Finan. -1 0 2 -1 1 4 0 0 0 0
Net Change 0 0 0 0 0 2 -2 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 2 0 0 0 0

Adline Chem Lab Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 31.46 31.46 30.45 30.17 30.17 30.17 28.24 28.24 28.24
Public 68.54 68.54 69.55 69.83 69.83 69.83 71.76 71.76 71.76
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Adline Chem Lab Ltd. Announcements

View details >>
Wed, 07 Jun 2023
Non Applicability Of Submission Of Related Party Transaction Disclosure In XBRL Mode Under Reg. 23(9) For The Period Ended March 31 2023
Please note that as per Regulation 15(2) of SEBI (LODR) Regulations 2015 the provisions of Regulation 23 of SEBI (LODR) Regulations 2015 are not applicable to the Company for the financial year 2022-23 as the paid up share capital of the Company as at 31st March 2022 was Rs. 5.85 Crore and the Net worth of the Company as at 31st March 2022 was Rs. 2.65 Crore. Hence the Company had not exceeded the prescribed threshold limits for applicability of provisions of Regulation 23 of SEBI (LODR) Regulations 2015 for the year 2022-23. Hence the Company is not required to submit disclosure of Related Party Transaction in XBRL Mode as required under Regulation 23(9) of SEBI LODR for the Period ended March 31 2023.
Wed, 31 May 2023
Draft Letter of Offer
Kunvarji Finstock Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the public shareholders of Adline Chem Lab Ltd ("Target Company").
Tue, 30 May 2023
Results- Financial Results For March 31 2023
Please note that the Board of Directors in their meeting held today i.e. on 30th May 2023 have approved the Audited Financial Results for the financial year 2022-23 ended on 31st March 2023.Pursuant to Regulation 33 of SEBI (LODR) Regulations 2015 we are enclosing herewith:1. Statement of Audited Financial Results for the year ended on 31st March 2023.2. Auditors Report on the Audited Financial Results3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March 2023

Adline Chem Lab Ltd. Technical Scans

View details >>
Tue, 06 Jun 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Adline Chem Lab Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Adline Chem Lab Ltd. FAQ's

What is Adline Chem Lab share price?
Can I buy Adline Chem Lab shares now?
What is the Market Cap of Adline Chem Lab?
What is the 52 Week High and Low of Adline Chem Lab?